| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/10/2006 | CN1771261A Antibodies against insulin-like growth factor I receptor and thereof |
| 05/10/2006 | CN1771254A Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 05/10/2006 | CN1771247A Oxime derivatives and their use as pharmaceutically active agents. |
| 05/10/2006 | CN1771243A Sulfamate benzothiophene ester derivatives as steroid sulfatase inhibitors |
| 05/10/2006 | CN1771235A Isoxazole compounds |
| 05/10/2006 | CN1771226A 2-propylidene-19-nor-vitamin d compounds |
| 05/10/2006 | CN1771049A Somatostatin-dopamine chimeric analogs |
| 05/10/2006 | CN1771042A Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents |
| 05/10/2006 | CN1770980A Pyrazoles and methods of making and using the same |
| 05/10/2006 | CN1769460A Recombinant chimeric eucaryotic expression vector Cb1-Grb7(SH2)-RING and use of anti-tumour gene drug |
| 05/10/2006 | CN1769447A Decoying oligodeoxynucleotides for suppressing chronic granulocyte leukemia STAT5 and its uses |
| 05/10/2006 | CN1769433A Recombinant vesicular stomatitis virus and its uses |
| 05/10/2006 | CN1769301A Microbe composite polysaccharide for suppressing cancer cell and its preparation method |
| 05/10/2006 | CN1769300A Tumour new-born blood vessel specific binding polypeptide CRGDC and novel recombinant tumor necrosis factor nrhTNF fusion protein and their preparation method |
| 05/10/2006 | CN1769284A Substituted 1H-indole-2-ketone compound and its preparation method and uses |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769281A Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents |
| 05/10/2006 | CN1769275A Taxane derivatives and processes for the preparation thereof |
| 05/10/2006 | CN1768873A Apparatus for electroporation mediated delivery for drugs and genes |
| 05/10/2006 | CN1768855A Medicine for treating cervical carcinoma, its preparation process and application |
| 05/10/2006 | CN1768837A Chinese medicine for treating malignant tumors |
| 05/10/2006 | CN1768808A Medicinal formulation for treating cancer and preparation method thereof |
| 05/10/2006 | CN1768795A Hawthorn fruit physiological activity |
| 05/10/2006 | CN1768789A Chinese medicinal formulation for treating malignant tumor and its preparation method |
| 05/10/2006 | CN1768787A Method for preparing cinobufotalin lyophilized powder |
| 05/10/2006 | CN1768774A Aucklandia root oil containing emulsion, its preparation process and use |
| 05/10/2006 | CN1768768A Chinese medicinal preparation for treating liver cancer and preparation process thereof |
| 05/10/2006 | CN1768754A Application of dipyridamole in preparation of anti-malignant tumor medicine |
| 05/10/2006 | CN1768737A Composition comprising demethylcantharidin in combination with platinum-containing anti-cancer agent and use thereof |
| 05/10/2006 | CN1768732A Application of aromatic nitro compound in preparation of medicine for treating tumor |
| 05/10/2006 | CN1768588A Cactus green tea(black tea) |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/10/2006 | CN1255428C Template-fixed peptidomimetics with antimicrobial activity |
| 05/10/2006 | CN1255427C Method and composition for treating liver cell cancer |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255391C COLCHINOL derivatives as vascular damaging agents |
| 05/10/2006 | CN1255381C Indigo derivative and its preparing process and application |
| 05/10/2006 | CN1255186C New use of gene mutant of human telomerase inverse transcriptase-like component |
| 05/10/2006 | CN1255182C Thymic peptide infusion and preparation process |
| 05/10/2006 | CN1255180C Chinese patent drug for treating female ovarian cyst and its preparation |
| 05/10/2006 | CN1255173C Medicine for treating cancer |
| 05/10/2006 | CN1255164C Chinese traditional medicine for treating acute leukemia |
| 05/10/2006 | CN1255137C Medicine for treating hysteromyoma |
| 05/10/2006 | CN1255124C Application of Psoralca corylifolia in anti-infection of helicobacter pyloric and treating relative diseases |
| 05/10/2006 | CN1255104C Camptothecine and hydroxy camptothecine lipid composition and its preparing method |
| 05/10/2006 | CN1255049C Functional agent for decomposing nicotine and method of preparing the same |
| 05/09/2006 | US7041834 alkylamination of N-methylcarbazol-5-one at the 6-position in the presence of formaldehyde, a secondary amine, and a desiccant; deamination and coupling of 2-methylimidazole at the 1-position; reaction time less than three hours |
| 05/09/2006 | US7041802 Peptidoglycan recognition proteins |
| 05/09/2006 | US7041794 Nucleotide sequence comprises at least one new SNP (single nucleotide polymorphism) |
| 05/09/2006 | US7041786 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 05/09/2006 | US7041701 Triterpenoid derivatives |
| 05/09/2006 | US7041699 Ascorbic compound; L-lysine compound; c) L-proline compound; and d) epigallocatechin gallate, epicatechin gallate, epigallocatechin, epicatechin, or catechin; blocking cancer proliferation and metastasis. |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041685 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/09/2006 | US7041676 Compounds, compositions, and methods |
| 05/09/2006 | US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 05/09/2006 | US7041663 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/09/2006 | US7041654 Treating or preventing cancer by administering to subject a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence |
| 05/09/2006 | US7041653 Gene transcription and ionizing radiation: methods and compositions |
| 05/09/2006 | US7041640 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/09/2006 | US7041504 Cancer cell-inhibiting culture medium produced by culturing restricted entrapped cancer cells |
| 05/09/2006 | US7041322 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 05/09/2006 | US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury |
| 05/09/2006 | US7041241 Microspheres contain 5-fluorouracil coated with poly(d-l-lactic acid-co-glycolic acid); implanted in walls of operation site following exeresis of tumor, by intratissular injection |
| 05/09/2006 | US7041063 Noninvasive measurement of chemical substances |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2388431C Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| 05/09/2006 | CA2322341C Highly resistant granular starch |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/09/2006 | CA2233716C Methods of using discodermolide compounds |
| 05/09/2006 | CA2205745C Method for the preparation of baccatin iii and derivatives thereof from 10-deacetylbaccatin iii |
| 05/09/2006 | CA2175687C A bacterial nitroreductase gene-prodrug system |
| 05/09/2006 | CA2156857C Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 05/04/2006 | WO2006047574A1 (2-carboxamido)(3-amino) thiophene compounds |
| 05/04/2006 | WO2006047504A1 Aromatic amides as inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047317A1 Pyrrolotriazine compounds |
| 05/04/2006 | WO2006047256A1 Triazoles useful as inhibitors of protein kinases |
| 05/04/2006 | WO2006047172A1 Tweak receptor |
| 05/04/2006 | WO2006046751A1 Anti-glypican 3 antibody having modified sugar chain |
| 05/04/2006 | WO2006046735A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 05/04/2006 | WO2006046584A1 Remedy for visual cell injuries |
| 05/04/2006 | WO2006046583A1 Material for regenerating visual cells or functions thereof |
| 05/04/2006 | WO2006046071A1 Compounds and compositions useful in the treatment of neoplasia |
| 05/04/2006 | WO2006045541A1 Treatment and prevention of multi-drug resistance |
| 05/04/2006 | WO2006045514A1 3-arylamino pyridine derivatives |
| 05/04/2006 | WO2006045238A1 Carbonized pollen and the use thereof for the preparation of anticancer drugs |
| 05/04/2006 | WO2006033913A3 Bis (thio-hydrazide amides) for treament of hyperplasia |
| 05/04/2006 | WO2006032537A3 Use of epothilones in the treatment of bone metastases and bone tumors or cancers |
| 05/04/2006 | WO2006032525A3 Combinational therapy for treating cancer |
| 05/04/2006 | WO2006031653A3 Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates |
| 05/04/2006 | WO2006021454A3 Pyrimidine derivatives |
| 05/04/2006 | WO2006018632A3 Cell therapy with exo 1 |
| 05/04/2006 | WO2006016276A3 Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor |
| 05/04/2006 | WO2006013376A3 Drug delivery of a cox inhibitor from embolic agents |
| 05/04/2006 | WO2006009809A3 Vegf inhibitors for the treatment of malignant pleural effusion |
| 05/04/2006 | WO2006007378A3 Pyrrolotriazine kinase inhibitors |